Why Early QC Planning Matters in Cell and Gene Therapy
June 30, 2026
Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes
7 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Fujifilm and HORIBA Develop Inline Raman System for Biomanufacturing
June 29, 2026
The system is designed for real-time monitoring of cell culture and purification, with Fujifilm reporting about a 10 percent yield improvement in antibody purification tests
2 min read
Bioprocessing
Interviews
Technology & Manufacturing
Digital Technologies
Quality & Compliance
Regulation & Standards
Standards & Regulation
Sponsored
How Zealand Pharma Is Scaling Quality Without Complexity
June 29, 2026
How connected quality systems can help growing biotechs remain agile.
0 min read
Biopharma Vital Signs – Part 2: Emerging Trends
June 26, 2026
Industry experts discuss the trends reshaping biotech and biopharma development – from complex modalities and manufacturing pressures to AI, funding constraints, and the growing need to plan for commercialization earlier
9 min read
Cell & Gene
Development & Clinical
Outsourcing
Regulation & Standards
Business & Trends
Technology & Manufacturing
Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?
June 25, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy
Unlocking the Sustainability Data Inside Biotech Operations
June 24, 2026
Connecting experimental, procurement, and facilities data could reveal major opportunities to reduce plastic use, energy consumption, and laboratory waste
6 min read
This Week’s CGT News: Gene Therapy Extends Health Span in Mice
June 23, 2026
A gene therapy preserves organ function and boosts life expectancy in mice, while base editing avoids some CRISPR damage in human embryos, and immune clues emerge for CAR T in glioblastoma
4 min read
Rewriting the Neuroscience Playbook
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
Improving Patient Outcomes Through Conjugation Chemistry
June 22, 2026
Why CDMO innovation is key to advancing next-generation oligonucleotide therapies
4 min read
In Vivo CRISPR Therapy Succeeds in Phase 3 Trial
June 22, 2026
A single infusion of Intellia’s in vivo gene-editing therapy reduced monthly hereditary angioedema attacks by 87 percent
3 min read
Biopharma Vital Signs – Part 1: Reading the Room at BIO
June 19, 2026
As BIO 2026 approaches, industry experts weigh in on the conversations likely to dominate the floor – from AI and funding pressures to manufacturing readiness, regulatory uncertainty, and the challenge of turning innovation into real-world impact
7 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.